
Myopia can lead to decreased visual acuity, causing cataracts, glaucoma,Retinopathysuch complications, progressing to blinding eye diseases. According to data released by the Bureau of Disease Control and Prevention under the National Health Commission, in recent years, the myopia rate among 6-year-old children has been 14.3%, 35.6% among primary school students, 71.1% among junior high school students, and 80.5% among senior high school students. Myopia has become highly prevalent among adolescents and is showing a trend toward affecting younger age groups. The harms of myopia cannot be overlooked; it urgently requires attention from all sectors of society to join forces in building a comprehensive system for myopia prevention and control.
At the policy level, national emphasis on eye health has reached an unprecedented height. In 2022, the National Health Commission released the “14th Five-Year Plan” for National Eye Health in China, which clarified the critical role of strengthening the construction of eye health information platforms in improving eye health outcomes. This provides strong policy support for the application of digital therapeutics in the prevention and treatment of ophthalmic diseases.
The application of digital therapeutics in ophthalmology is becoming increasingly widespread, emerging as a crucial tool for enhancing the standard of ophthalmic diagnosis and treatment. By integrating big data analytics, artificial intelligence, and mobile health technologies, digital therapeutics offer innovative solutions for the prevention, diagnosis, treatment, and rehabilitation of ocular diseases. For instance, digital therapeutics have been applied to the personalized management of myopia, leveraging smart devices and applications to assist patients with vision monitoring, early disease screening, and the provision of individualized treatment plans. Furthermore, in glaucoma,Macular DegenerationIn the long-term management of chronic ophthalmic diseases, digital therapeutics have also played a significant role, enhancing treatment precision and patient adherence.Digital therapeutics are driving a transformation in ophthalmic care from a traditional treatment-centric model to one focused on prevention, personalized intervention, and comprehensive lifecycle management.
Organized by Beijing Danhuang Technology Co., Ltd.,Hainan Eco-Software Park, Shuimu JinshengThe 2024 Digital Therapeutics Conference, in strategic partnership with8Month30June 30–July 1, at the Hilton Haikou Meilan Hotel in Haikou, Hainanheld. Among them,byHainan Provincial Eye HospitalCo-hosted byForum on Digital Healthcare Innovation in OphthalmologyScheduled for August 30 at the Hilton Haikou Meilan, Haikou, HainanMeilan Hall ABHosted.

(Free Registration)

Conference Introduction

Conference Name:2024 Digital Therapeutics Conference
Conference Time:2024August 30–31
Conference Venue:Hainan · Haikou Luneng Hilton Hotel
Supporting Organizations:Young Health Economics Committee of the Chinese Society of Health Economics, Health Industry Branch of the Chinese Society of Health Economics, Digital Therapeutics Professional Committee of the China Association for Medical Device Industry, Medical and Health Industry Branch of the China Information Association, Digital Health Professional Committee of the China Association for Promotion of Industrialization of Science and Technology, Big Data and Artificial Intelligence Professional Committee on Maternal and Child Health of the China Association of Maternal and Child Health, Beijing Society for Human Injury Repair Research, China Medicine Biotechnology Association,Hainan Province Non-Public Medical Institutions Association

(Free Registration)

If you are interested in going global,Welcome to share this article and add VBEF Overseas Expansion: Pitfall Avoidance Guide, Resource Exchange, and Matchmaking Consultant, to learn more about the latest insights on global expansion!VCBeat looks forward to riding the winds and waves with you!
